Elevated thymidine kinase 1 expression at baseline predicts poor prognosis in breast cancer patients

Key Points

• High baseline thymidine kinase 1 expression predicts significantly worse prognostic outcomes in breast cancer patients.
• Patients with elevated TK1 expression face notably poorer prognostic metrics, emphasizing its clinical relevance.
• This observational analysis highlights the importance of TK1 assessment for risk stratification in breast cancer management.
• Further validation through large-scale, multicenter clinical trials is needed to confirm these findings.